Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hemant Surgical IndustriesBOM:543916 +1.00%77 3-Year ROIIC % is 7.19 as of Mar. 2026, which is at its 10-year median of 7.19. GuruFocus rates BOM:543916 with a GF Score™ of 77/100 and a GF Value™ of ₹339.81 (Fairly Valued). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Hemant Surgical Industries ranks better than 58.11% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Hemant Surgical Industries's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 7.19%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Hemant Surgical Industries's 3-Year ROIIC % or its related term are showing as below:
BOM:543916's 3-Year ROIIC % is ranked better than 58.11% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.33
vs BOM:543916: 7.19
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Hemant Surgical Industries 3-Year ROIIC % Related Terms
Hemant Surgical Industries 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543916 vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Hemant Surgical Industries's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemant Surgical Industries 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hemant Surgical Industries's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Hemant Surgical Industries's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Hemant Surgical Industries (BOM:543916) has a 3-Year ROIIC % of 7.19 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Hemant Surgical Industries and its competitors. This is near median its historical median of 7.19. Over the past decade, Hemant Surgical Industries' 3-Year ROIIC % has ranged from 1.27 to 20.15. According to the industry distribution chart, Hemant Surgical Industries ranks #333 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 41.9%.
Is Hemant Surgical Industries' 3-Year ROIIC % too high?
Hemant Surgical Industries' current 3-Year ROIIC % of 7.19 is near median its 10-year median of 7.19. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 20.15. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.33. Hemant Surgical Industries' value of 7.19 is 440.6% above this industry median. Based on the distribution chart, Hemant Surgical Industries ranks #333 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Hemant Surgical Industries has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hemant Surgical Industries' 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hemant Surgical Industries ranks #333 out of 795 companies for 3-Year ROIIC %. This puts Hemant Surgical Industries in the upper half of its industry. The industry median 3-Year ROIIC % is 1.33. Hemant Surgical Industries' value of 7.19 is 440.6% above this benchmark. Historically, Hemant Surgical Industries' own 3-Year ROIIC % has ranged from 1.27 to 20.15 over the past decade. While the company's 10-year median is 7.19 vs. the industry median of 1.33, Hemant Surgical Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.33, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hemant Surgical Industries's current 3-Year ROIIC % of 7.19 is 440.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Hemant Surgical Industries and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemant Surgical Industries's current 3-Year ROIIC % is 7.19, which is near median its own 10-year median of 7.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemant Surgical Industries stock overvalued right now?
Based on GuruFocus' analysis, Hemant Surgical Industries (BOM:543916) is currently considered Fairly Valued. The stock's GF Value™ is ₹339.81, compared to a current price of ₹372.35 — trading 9.6% above its estimated fair value. The current 3-Year ROIIC % is 7.19, which is near median its 10-year median of 7.19 and 440.6% above the Medical Devices & Instruments industry median of 1.33. Hemant Surgical Industries' overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Hemant Surgical Industries (BOM:543916), the current 3-Year ROIIC % is 7.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hemant Surgical Industries (BOM:543916) Overvalued in 2026?
Based on GuruFocus' analysis, Hemant Surgical Industries stock appears to be overvalued.
The current stock price of ₹372.35 is trading 9.6% above its estimated GF Value™ of ₹339.81.
GuruFocus considers Hemant Surgical Industries to be Fairly Valued.
Key valuation signals for BOM:543916:
3-Year ROIIC %: 7.19 (near median its 10-year median of 7.19)
GF Value™: ₹339.81 vs. price of ₹372.35 (9.6% above fair value)
Industry Position: 440.6% above the Medical Devices & Instruments median (#333 of 795)
No single metric tells the full story. See the BOM:543916 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease, (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.
77GF Score
Get the complete analysis for BOM:543916
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543916 has been successfully added to your 
